Draft Genome Sequence of Linezolid-Resistant Enterococcus faecalis Clinical Isolate HS0914

Area of Science:

• Microbiology
• Genomics
• Infectious Diseases

Background:

• Enterococcus faecalis is a significant nosocomial pathogen.
• Linezolid is a critical antibiotic for treating resistant Gram-positive infections.
• Emergence of linezolid resistance in E. faecalis poses a global health threat.

Purpose of the Study:

• To perform whole-genome sequencing of a linezolid-resistant Enterococcus faecalis strain (HS-0914).
• To identify genetic determinants of linezolid resistance in this clinical isolate.
• To provide genomic data for understanding resistance mechanisms in E. faecalis.

Main Methods:

• Whole-genome sequencing using next-generation sequencing technology.
• Bioinformatic analysis for genome assembly and gene identification.
• Comparative genomics to identify resistance-associated genes.

Main Results:

• The draft genome sequence of E. faecalis HS-0914 comprises 61 contigs and 2,816,079 base pairs.
• Absence of known linezolid resistance determinants, including ribosomal RNA mutations and the cfr gene.
• Identification of potential novel or uncharacterized resistance mechanisms.

Conclusions:

• The sequenced linezolid-resistant E. faecalis strain HS-0914 lacks common resistance genes.
• Further investigation is required to elucidate the specific mechanisms conferring linezolid resistance in this strain.
• This genomic resource aids in understanding the evolution and spread of antibiotic resistance in E. faecalis.